СОВРЕМЕННЫЕ ПОДХОДЫ К ТЕРАПИИ БОЛЕВЫХ СИНДРОМОВ ПРИ ПОРАЖЕНИЯХ МЯГКИХ ТКАНЕЙ


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Доступ платный или только для подписчиков

Аннотация

В статье представлены сведения о принципах лечения поражений мягких тканей. Препарат Траумель С предлагает альтернативный подход к лечению воспаления и устранению боли - основных симптомов при травмах мягких тканей. Недавно доказано, что при местном применении Траумель С не хуже, чем диклофенак, купирует боль и улучшает функции при остром растяжении связок голеностопного сустава. Для использования Траумеля С в клинической практике группой международных экспертов был разработан специальный алгоритм лечения.

Полный текст

Доступ закрыт

Об авторах

К. Спид

Центр здоровья Кембридж; Университет St. Mark & St. John; Английский институт спорта

Email: speed@fortiusclinic.com
к.м.н., дипломированный специалист по спортивной медицине, Член Королевского терапевтического колледжа, проф. спортивной медицины Главный врач сотрудник Великобритания

Б. Вольфарт

Центр здоровья Кембридж

Великобритания

Список литературы

  1. Speed C., Hazleman B., Dalton S. Fast Facts: Soft Tissue Disorders, 2nd ed. Oxford: Health Press. Limited. 2006.
  2. Selvanetti A. Overuse tendon injuries: basic science and classification. Operat. Tech. Sports Med. 1997;5:110-17.
  3. Bahr R. No injuries, but plenty of pain? On the methodology for recording overuse symptoms in sports. Br. J. Sports Med. 2009;43:966-72.
  4. van Tulder M., Malmivaara A., Koes B. Repetitive strain injury. Lancet 2007;369:1815-22.
  5. Laker S.R., Sullivan W.J., Strum S. Overuse injury. Medscape. 2008. Available at: http://emedicine. medscape.com/article/313121-overview.
  6. Paoloni J.A., Milne C., Orchard J., Hamilton B. Non-steroidal anti-inflammatory drugs in sports medicine: guidelines for practical but sensible use. Br. J. Sports Med. 2009;43:863-65.
  7. Coxib and traditional NSAID Trialists' (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013; 382:769-79.
  8. Trelle S., Reichenbach S., Wandel S., Hildebrand P., Tschannen B., Villiger P.M., Egger M., Jüni P. Cardiovascular safety of non-steroidal antiinflammatory drugs: network analysis. BMJ. 2011;342:c7086.
  9. Castellsague J., Riera-Guardia N., Calingaert B., et al.; on behalf of the investigators of the Safety of Non-Steroidal Anti-inflammatory Drugs (SOS) Project. Individual NSAIDs and upper gastrointestinal complications. A systematic review and meta-analysis of observational studies (the SOS Project). Drug. Saf. 2012; 35:1127-45.
  10. Barkin R.L, Beckerman M., Blum S.L., Clark F.M., Koh E.K, Wu D.S. Should nonsteroidal antiinflammatory drugs (NSAIDs) be prescribed to the older adult? Drugs Aging. 2010;27:775-89.
  11. Evans J.M., McMahon A.D., McGilchrist M.M., White G., Murray F.E., McDevitt D.G., MacDonald T.M. Topical non-steroidal antiinflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study. BMJ. 1995;311:22-6.
  12. Antman E.M., Bennett J.S., Daugherty A., et al.; for the American Heart Association. Use of nonsteroidal anti-inflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 2007;115:1634-42.
  13. Evans J.M., McGregor E., McMahon A.D., McGilchrist M.M., Jones M.C., White G., McDevitt D.G., MacDonald T.M. Nonsteroidal anti-inflammatory drugs and hospitalization for acute renal failure. QJM. 1995;88:551-57.
  14. Laine L., Goldkind L., Curtis S.P., Connors L.G., Yanqiong Z., Cannon C.P How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial. Am. J. Gastroenterol. 2009;104:356-62.
  15. Barkin R.L. Topical nonsteroidal antiinflammatory drugs: the importance of drug, delivery, and therapeutic outcome. Am. J. Ther. 2012: published online 22 February 2012, doi: 10.1097/MJT.0b013e3182459abd.
  16. FitzGerald G.A., Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N. Engl. J. Med. 2001;345:433-42.
  17. Brewer A.R., McCarberg B., Argoff C.E. Update on the use of topical NSAIDs for the treatment of soft tissue and musculoskeletal pain: a review of recent data and current treatment options. Phys. Sportsmed. 2010;38:62-70.
  18. Kienzler J.L., Gold M., Nollevaux F. Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers. J. Clin. Pharmacol. 2010;50:50-61.
  19. Heyneman C.A., Lawless-Liday C., Wall G.C. Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs. 2000;60:555-74.
  20. Argoff C.E. Topical analgesics in the management of acute and chronic pain. Mayo. Clin. Proc. 2013;88:195-205.
  21. Singh P., Roberts M.S. Skin permeability and local tissue concentrations of nonsteroidal antiinflammatory drugs after topical application. J. Pharmacol. Exp. Ther. 1994;268:144-51.
  22. Radermacher J., Jentsch D., Scholl M.A., Lustinetz T., Frölich J.C. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br. J. Clin. Pharmacol. 1991;31:537-41.
  23. Brune K. Persistence of NSAIDs at effect sites and rapid disappearance from side-effect compartments contributes to tolerability. Curr. Med. Res. Opin. 2007;23:2985-95.
  24. Wolfe M.M., Lichenstein D.R., Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 1999;340:1888-99.
  25. McGettigan P., Henry D. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS. Med. 2011;8:e1001098.
  26. Barbe M.F., Barr A.E. Inflammation and the pathophysiology of work-related musculoskeletal disorders. Brain Behav. Immun. 2006; 20:423-29
  27. Barr A.E., Barbe M.F., Clark B.D. Systemic inflammatory mediators contribute to widespread effects in work-related musculoskeletal disorders. Exerc. Sport. Sci. Rev. 2004;32:135-42.
  28. Mueller-Wohlfahrt H.-W., Haensel L., Mithoefer K., Ekstrand J., English B., McNally S., Orchard J., van Dijk C.N., Kerkhoffs G.M., Schamasch P., Blottner D., Swaerd L., Goedhart E., Ueblacker P. Terminology and classification of muscle injuries in sport: the Munich consensus statement. Br. J. Sports Med. 2013;47:342-50.
  29. Ziltener J.-L., Leal S., Fournier P-E. Non-steroidal anti-inflammatory drugs for athletes: an update. Ann. Phys. Rehab. Med. 2010;53:278-88.
  30. Orchard J.W., BestT.M., Mueller-Wohlfahrt H.-W., Hunter G., Hamilton B.H., Webborn N., Jaques R., Kenneally D., Budgett R., Phillips N, Becker C., Glasgow P. The early management of muscle strains in the elite athlete: best practice in a world with a limited evidence basis. Br. J. Sports Med. 2008;42:158-59.
  31. Orchard J., Best T.M. The management of muscle strain injuries: an early return versus the risk of recurrence. Clin. J. Sports. Med. 2002;12:3-5.
  32. Kannus P., Parkkari J., Jarvinen T.L.N., et al. Basic science and clinical studies coincide: active treatment approach is needed after a sports injury. Scand. J. Med. Sci. Sports. 2003 13:150-54.
  33. Cesnulevicius K. The bioregulatory approach to work-related musculoskeletal disorders: using the multicomponent ultra low-dose medication Traumeel to target the multiple pathophysiological processes of the disease. Altern. Ther. Health Med. 2011; 17(Suppl. 2):8-17.
  34. Lussignoli S., Bertani S., Metelmann H., Bellavite P., Conforti A. Effect of Traumeel S, a homeopathic formulation, on blood-induced inflammation in rats. Complement. Ther. Med. 1999;7:225-30.
  35. Zell J., Connert W.D., Mau J., Feuerstake G. Behandlung von akuten Sprunggelenksdistorsionen: doppelblindstudie zum Wirksamkeitsnachweis eines homo-opathischen Salbenpraparats. Fortschr. Med. 1988;106:96-100. English translation available in: Zell J, Connert W.D., Mau J., Feuerstake G. Treatment of acute sprains of the ankle: a controlled double-blind trial to test the effectiveness of a homeopathic ointment. Biol. Ther. 1989;7:1-6.
  36. Böhmer D., Ambrus P. Treatment of sports injuries with Traumeel ointment: a controlled doubleblind study. Biol. Ther. 1992;10:290-300.
  37. Thiel W., Borho B. Posttraumatische Kniege-lenksergusse und intra-artikulare Traumeel Injektion. Orthopadische. Praxis. 1991; 11:721-25.
  38. Orizola A.J., Vargas F The efficacy of Traumeel S versus diclofenac and placebo ointment in tendinous pain in elite athletes: a randomized controlled trial. Med. Sci. Sports Med. Exerc. 2007;39(Suppl. 5):S79, abstract 858.
  39. Gonzalez de Vega C., Speed C., Wolfarth B., et al. Traumeel vs. diclofenac for reducing pain and improving ankle mobility after acute ankle sprain: a multicentre, randomised, blinded, controlled and non-inferiority trial. Int. J. Clin. Pract. 2013; 67:979-89.
  40. Wolfarth B., Gonzalez de Vega C. Make an impact on your daily practice: the potential role for a natural multi-target medication. Curr. Med. Res. Opin. 2013.29(Suppl. 2):15-9.
  41. Schneider C. Traumeel - an emerging option to nonsteroidal anti-inflammatory drugs in the management of acute musculoskeletal injuries. Int. J. Gen. Med. 2011;4:225-34.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ООО «Бионика Медиа», 2016

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах